ESC 365 - Arrest of progression of cardiac amyloidosis after chemotherapy predicts favorable outcome in patients with light-chain amyloidosis

ESC Premium Access

Arrest of progression of cardiac amyloidosis after chemotherapy predicts favorable outcome in patients with light-chain amyloidosis

Session: Poster Session 1

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Koyama (Ueda, JP)

Event: ESC Asia with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Doctor Jun Koyama

Maruko Central Hospital, Ueda (Japan)

1 presentation

0 follower

32 more presentations in this session

Clinical utility of stress echocardiography in remote indigenous and non-indigenous populations: a 10-year study in central Australia

Speaker: Doctor S. Ratwatte (Sydney, AU)

Characterisation of right heart dysfunction in left ventricular systolic failure

Speaker: Doctor H. Chen (Sydney, AU)

The impact of coronary calcification on diagnostic performance of workstation CT derived fractional flow reserve - a multicentre experience

Speaker: Ms M. Isa (Melbourne, AU)

Efficacy and safety of catheter ablation combined with left atrial appendage occlusion in patients with atrial fibrillation over one year: first results in a Chinese population

Speaker: Mr F. Xiao (Wenzhou, CN)

Novel use of CHA2DS2VASC score to select patients to undergo repeat atrial fibrillation screening

Speaker: Doctor W. Sun (Shatin, HK)

Access the full session

Poster Session 1

Speakers: Doctor J. Koyama, Doctor S. Ratwatte, Doctor H. Chen, Ms M. Isa, Mr F. Xiao...

About the event

ESC Asia with APSC & AFC

8 November - 10 November 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources